Straits Times Index
3,269.27 -32.69 (-0.99%) Nikkei
28,546.98 +727.65 (+2.62%) Hang Seng
20,175.62 +93.19 (+0.46%) FTSE 100
7,500.89 +34.98 (+0.47%) BTC-USD
24,161.46 -102.52 (-0.42%) CMC Crypto 200
574.64 +3.36 (+0.59%)
Eupraxia Pharmaceuticals Inc. (EPRX.TO)
| Previous close | 1.0800 |
| Open | 1.0800 |
| Bid | 0.9600 x N/A |
| Ask | 1.0500 x N/A |
| Day's range | 0.9500 - 1.0800 |
| 52-week range | 0.8000 - 3.5000 |
| Volume | |
| Avg. volume | 22,450 |
| Market cap | 20.323M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2720 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.75 |
- CNW Group
Eupraxia Pharmaceuticals Reports Second Quarter 2022 Financial Results
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced its unaudited financial results (prepared in accordance with International Financial Reporting Standards or "IFRS") and operational highlights for the second quarter ended June 30, 2022. All amounts are expressed in Canadian dollars unless otherwise indicated.
- CNW Group
Eupraxia Pharmaceuticals Recognized as Emerging Life Sciences Company of the Year by Life Sciences British Columbia
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery platform technology, announced today that it has been awarded The Emerging Life Sciences Company of the Year Award by Life Sciences British Columbia ("LSBC").
- CNW Group
Eupraxia Pharmaceuticals to Present at BIO International Convention
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) a clinical-stage biotechnology company with an innovative drug delivery platform technology, announced today that its CEO, Dr. James Helliwell, will present at the 2022 Bio International Convention being held at the San Diego Convention Center from June 13-16, 2022, in San Diego, CA.
